Nakanishi, Yu <br/><br/>
Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer.  [electronic resource] 

 -  International journal of clinical oncology  Jan 2020 
 - 74-81 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1437-7772 
<br/><br/><label>Standard No.: </label>10.1007/s10147-019-01539-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Immunological--therapeutic use<br/>Biomarkers, Tumor--blood<br/>Carcinoma, Non-Small-Cell Lung--blood<br/>Female<br/>Humans<br/>Lung Neoplasms--blood<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Programmed Cell Death 1 Receptor--agonists<br/>Retrospective Studies<br/>Serum Albumin--analysis<br/>Serum Globulins--analysis<br/>Survival Analysis